AAAAAA

   
Results: 1-10 |
Results: 10
Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer
Authors: Bennett, JJ Tjuvajev, J Johnson, P Doubrovin, M Akhurst, T Malholtra, S Hackman, T Balatoni, J Finn, R Larson, SM Federoff, H Blasberg, R Fong, YM
Citation: Jj. Bennett et al., Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer, NAT MED, 7(7), 2001, pp. 861-865
Combination vascular delivery of herpes simplex oncolytic viruses and amplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer
Authors: Zager, JS Delman, KA Malhotra, S Ebright, MI Bennett, JJ Kates, T Halterman, M Federoff, H Fong, YM
Citation: Js. Zager et al., Combination vascular delivery of herpes simplex oncolytic viruses and amplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer, MOL MED, 7(8), 2001, pp. 561-568
Effective treatment of pancreatic tumors with two multimutated herpes simplex oncolytic viruses
Authors: McAuliffe, PF Jarnagin, WR Johnson, P Delman, KA Federoff, H Fong, YM
Citation: Pf. Mcauliffe et al., Effective treatment of pancreatic tumors with two multimutated herpes simplex oncolytic viruses, J GASTRO S, 4(6), 2000, pp. 580-587
Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer
Authors: Bennett, JJ Kooby, DA Delman, K McAuliffe, P Halterman, MW Federoff, H Fong, YM
Citation: Jj. Bennett et al., Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer, J MOL MED-J, 78(3), 2000, pp. 166-174
Efficient cotransduction of tumors by multiple herpes simplex vectors: Implications for tumor vaccine production
Authors: Karpoff, HM Kooby, D D'Angelica, M Mack, J Presky, DH Brownlee, MD Federoff, H Fong, YM
Citation: Hm. Karpoff et al., Efficient cotransduction of tumors by multiple herpes simplex vectors: Implications for tumor vaccine production, CANC GENE T, 7(4), 2000, pp. 581-588
Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model
Authors: Jarnagin, WR Delman, K Kooby, D Mastorides, S Zager, J Brennan, MF Blumgart, LH Federoff, H Fong, Y
Citation: Wr. Jarnagin et al., Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model, ANN SURG, 231(5), 2000, pp. 762-769
Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity
Authors: D'Angelica, M Tung, C Allen, P Halterman, M Delman, K Delohery, T Klimstra, D Brownlee, M Federoff, H Fong, YM
Citation: M. D'Angelica et al., Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity, MOL MED, 5(9), 1999, pp. 606-616
In vivo interleukin-2 gene therapy of established tumors with herpes simplex amplicon vectors
Authors: D'Angelica, M Karpoff, H Halterman, M Ellis, J Klimstra, D Edelstein, D Brownlee, M Federoff, H Fong, YM
Citation: M. D'Angelica et al., In vivo interleukin-2 gene therapy of established tumors with herpes simplex amplicon vectors, CANCER IMMU, 47(5), 1999, pp. 265-271
Lentivirus vectors using human and simian immunodeficiency virus elements
Authors: White, SM Renda, M Nam, NY Klimatcheva, E Zhu, YH Fisk, J Halterman, M Rimel, BJ Federoff, H Pandya, S Rosenblatt, JD Planelles, V
Citation: Sm. White et al., Lentivirus vectors using human and simian immunodeficiency virus elements, J VIROLOGY, 73(4), 1999, pp. 2832-2840
Efficient gene transfer to human squamous cell carcinomas by the herpes simplex virus type 1 amplicon vector
Authors: Carew, JF Federoff, H Halterman, M Kraus, DH Savage, H Sacks, PG Schantz, SP Shah, JP Fong, YM
Citation: Jf. Carew et al., Efficient gene transfer to human squamous cell carcinomas by the herpes simplex virus type 1 amplicon vector, AM J SURG, 176(5), 1998, pp. 404-408
Risultati: 1-10 |